J&J | JNJ

Stock Price
163.01
Daily Change
-1.26 -0.77%
Monthly
2.10%
Yearly
4.65%
Q1 Forecast
162.30


Peers Price Chg Day Year Date
AbbVie 212.24 -1.67 -0.78% 20.41% Mar/19
Abbott 127.63 1.45 1.15% 14.47% Mar/19
Amgen 315.66 -3.25 -1.02% 15.61% Mar/19
AstraZeneca 11,784.00 -62.00 -0.52% 15.94% Mar/19
Baxter International 34.06 -0.46 -1.33% -18.58% Mar/19
Bayer 24.39 -0.38 -1.51% -6.98% Mar/19
Becton, Dickinson and Co. 231.84 -0.45 -0.19% -2.54% Mar/19
Biogen 141.45 -1.57 -1.09% -35.30% Mar/19
Bristol-Myers Squibb 60.04 0.05 0.08% 15.73% Mar/19
Boston Scientific 100.72 1.46 1.47% 49.35% Mar/19
CONMED 58.91 -1.70 -2.80% -22.58% Mar/19
Cooper Companies 80.13 0.13 0.16% -21.63% Mar/19
Dexcom 73.36 2.67 3.77% -44.65% Mar/19
Edwards Lifesciences 70.82 0.50 0.70% -23.88% Mar/19
Gilead Sciences 107.47 -2.54 -2.31% 45.27% Mar/19
Globus Medical 73.31 1.72 2.40% 41.44% Mar/19
GlaxoSmithKline 1,505.00 -26.50 -1.73% -8.61% Mar/19
Hologic 61.47 -0.51 -0.82% -18.08% Mar/19
Integra LifeSciences 22.84 0.22 0.97% -33.04% Mar/19
Indivior 764.50 14.50 1.93% -52.43% Mar/19
Intuitive Surgical 491.65 7.70 1.59% 25.94% Mar/19
J&J 163.01 -1.26 -0.77% 4.65% Mar/19
Eli Lilly 836.93 14.73 1.79% 8.29% Mar/19
Medtronic 91.86 -0.26 -0.28% 9.31% Mar/19
Merit Medical Systems 101.46 1.51 1.51% 39.20% Mar/19
Merck 93.94 -0.72 -0.76% -24.15% Mar/19
Novartis 98.24 -0.19 -0.19% 15.43% Mar/19
Pfizer 26.17 -0.15 -0.57% -5.52% Mar/19
Insulet 265.82 5.35 2.05% 58.98% Mar/19
Regeneron Pharmaceuticals 671.67 6.54 0.98% -30.54% Mar/19
Roche Holding 306.00 -3.20 -1.03% 32.50% Mar/19
Sanofi 107.98 0.34 0.32% 23.21% Mar/19
Stryker 377.94 1.86 0.49% 7.01% Mar/19
Teva Pharmaceutical Industries 6,013.00 59.00 0.99% 23.32% Mar/19
Tandem Diabetes Care 20.62 0.56 2.79% -36.48% Mar/19
Vertex Pharmaceuticals 512.37 0.01 0.002% 24.33% Mar/19
Zimmer Biomet Holdings 113.36 0.59 0.52% -10.41% Mar/19
Zoetis 163.76 -0.42 -0.26% -4.23% Mar/19

Indexes Price Day Year Date
US500 5695 60.63 1.08% 8.66% Mar/20
US30 42082 383.32 0.92% 5.78% Mar/20

Johnson & Johnson traded at $163.01 this Wednesday March 19th, decreasing $1.26 or 0.77 percent since the previous trading session. Looking back, over the last four weeks, J&J lost 2.10 percent. Over the last 12 months, its price rose by 4.65 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 162.30 by the end of this quarter and at 160.36 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.